Malignant hyperthermia (MH) is a hypermetabolic disorder of skeletal muscle triggered by certain anaesthetic agents. On rare occasions non-anaesthetic factors have caused a similar syndrome in susceptible individuals. A woman who is malignant hyperthermia susceptible (MHS) has increased risks associated with labour, especially the management of emergency caesarean section. There are also potential risks for the newborn. This paper reviews our experience since 1990 with parturients susceptible to malignant hyperthermia.
Malignant hyperthermia (MH) is a hypermetabolic disorder of skeletal muscle triggered by certain anaesthetic agents. On rare occasions non-anaesthetic factors have caused a similar syndrome in susceptible individuals. A woman who is malignant hyperthermia susceptible (MHS) has increased risks associated with labour, especially the management of emergency caesarean section. There are also potential risks for the newborn. This paper reviews our experience since 1990 with parturients susceptible to malignant hyperthermia.
METHOD
Palmerston North Hospital has approximately 2000 deliveries per year from a population of 150,000 and supports four small regional maternity units. This population has four MHS families and the largest of these has 1400 members documented over eight generations. Of our surgical population, 0.5-1% are MHS, or MH related, and up to 10 deliveries per year are children of MHS individuals.
We prospectively identified MHS women and partners of MHS men, who were delivering at Palmerston North Hospital from 1990 onwards. Three deliveries prior to 1990 are also included as most clinical details were available (patients 1A, 2A, 2B). We assessed each delivery for signs of an MH reaction induced by the stress of labour, and reviewed the use of drugs, particularly sympathomimetics. These results and assessment of the neonate are described.
Prior to 1990 the majority of MHS or MH related parturients were not identified until seen by an anaesthetist at the time of epidural for pain relief in labour or at caesarean section. Improved management was necessary and in 1990 a protocol for the management of the MHS parturient was introduced.
MANAGEMENT PROTOCOL Notification and Counselling
All women presenting for antenatal care in the region are required to complete a questionnaire including a question relating to MH. It is recommended that all MHS women are referred to a hospital with specialist obstetric and anaesthetic services. The notes of MHS parturients and of partners of MHS individuals who are identified are prominently labelled. A referral is sent to the Anaesthetic Department, and lists of the estimated date of delivery of these patients are displayed prominently in the operating theatre and delivery suite. Labour management is discussed at an antenatal visit by one of us (usually E.L.) and the patients are assessed for other potential anaesthetic problems in the usual way.
Labour Management
Anaesthetic staff are notified when an MHS parturient arrives in the delivery suite. An intravenous line is inserted and blood taken for haematology, biochemistry and creatine kinase (CK). Management of labour is again discussed with the woman and attending obstetric staff. Epidural analgesia is started early in labour, to reduce the stress of labour to both mother and baby, and to be ready for instrumental or operative delivery if required. Pulse, temperature and blood pressure are recorded hourly and foetal heart rate monitored. Arterial blood gases are measured only if the temperature is greater than 38.0°C, or there is a sustained tachycardia >120 bpm, or there are other abnormal signs present. Ranitidine 150 mg orally is administered 8 hourly.
An operating theatre is prepared by removing all anaesthesia vaporizers and leaving it empty for one hour. A dedicated vapour-free anaesthesia machine is placed in the prepared theatre. Dantrolene and resuscitation drugs are immediately available, and the theatre contains a supply of normal saline for infusion stored at 4°C.
Caesarean Section
Regional Anaesthesia:
For elective caesarean section the parturient is admitted the day before surgery and baseline blood tests, including creatine kinase, are performed. Dantrolene prophylaxis is not used. Antacid prophylaxis is used in standard doses. A paediatrician is notified of all susceptible patients, and is present at caesarean delivery.
Epidural or subarachnoid anaesthesia is used according to the anaesthetist's preference. No restriction has been placed on the use of adrenalinecontaining local anaesthetic solutions or other sympathomimetics. Oxytocin is regarded as a safe drug and ergometrine would be used if indicated.
During caesarean section there is continuous monitoring of rectal temperature, pulse rate, SpO 2 , and ECG and more recently ETCO 2 by nasal prongs. Initially we used an arterial line for continuous arterial pressure measurement, and for blood gases. Our policy has now changed, and noninvasive blood pressure monitoring at five minute intervals is used.
Arterial blood gases are now measured intraoperatively only during emergency caesarean section. If there is an abnormality serial measurements are continued post partum. Occasionally the screening procedure fails, so in the anaesthetic room the surname of each patient is checked against the list of MH families and this may be the first indication of the risk of malignant hyperthermia.
General Anaesthesia:
Careful assessment of the ability to intubate, the use of trigger-free anaesthetic agents, and monitoring and theatre preparation as described above are the basic principles of management. Intraoperative and postoperative arterial blood gases are required in this group. The options for induction, intubation, and maintenance are covered in Discussion.
Post Partum
Postoperatively the patient is observed in recovery for two hours after regional anaesthesia and rectal temperature, heart rate, ECG, and SpO 2 continuously monitored (four hours for general anaesthesia). Arterial blood gases are measured within one hour postoperatively if indicated. CK is measured at 24 hours. If the base deficit is greater than 8 mmol, temperature >38.0°C, or a sustained tachycardia greater than 120 bpm, consideration is given to the use of dantrolene and to intensive care admission.
After vaginal delivery, hourly blood pressure, pulse and temperature measurement continue for four hours post partum in the delivery suite or the post partum ward. Neonatal temperature, heart rate, and respiratory rate are recorded hourly for four hours.
Partner (Father of Newborn) at Risk of MH
These women form a special group. They are not themselves at risk. However, the newborn has a 50% chance of susceptibility as there is autosomal dominant inheritance. If general anaesthesia is required for caesarean section, suxamethonium and volatile agents are avoided. An epidural in labour is advised in this group of patients. The foetal heart is continuously monitored in labour and the newborn are monitored as above. 
MH SUSCEPTIBILITY

RESULTS
Sixteen women having 28 deliveries were identified. Eleven MHS women had 20 deliveries at Palmerston North Hospital. These women had another eight deliveries at other maternity units during the study period which are not included in the analysis. Patient ages ranged from 16-34 years. Seven of the women were primiparous. In all of these deliveries no woman developed pre-eclampsia. Patient 5 developed gestational diabetes during some of her pregnancies.
Five women with MHS partners had eight deliveries.
A further eleven women (11 deliveries) were managed as MHS but have subsequently tested MHN-normal (six women) or have not yet undergone muscle biopsy. These individuals have not been included in the following results. Table 2 summarizes the mode of delivery. All caesarean sections were managed with regional anaesthesia, and four were emergency procedures. The group with spontaneous vaginal delivery had a duration of labour ranging from 2 to 27 hours. Four women in this group were in labour for >12 hours. In those with an epidural, onset of labour to establishment of the epidural averaged five hours (despite guidelines to establish epidural early in labour). This indicates significant stress was involved.
Pulse, temperature, and blood pressure were measured regularly in all and SpO 2 , arterial blood gases, CK and cardiac rhythm in some of the deliveries ( clinical grading scale as devised by Larach et al were used to assess these findings 2 . Our policy regarding arterial blood gas measurement changed during the six-year period. Indications initially were to measure ABGs in all patients. Patient, midwife and some anaesthetic resistance to this invasive procedure restricted measurement in early years. This partly accounted for the measurement of arterial blood gases in only 6 of 20 during parturition and only twice during labour. Later, lack of evidence of MH reactions in this group of women and in literature reports (see Discussion) resulted in our present policy of ABG measurements as stated under labour management.
Signs consistent with an MH reaction
Only three deliveries (2A, 6, 5A) had abnormal clinical indicators that achieved any score on the MH grading scale. We carried out investigations at a temperature lower than that regarded as significant on the grading scale, and so are unlikely to have missed other clinical indicators.
One parturient developed a temperature >38.0°C. Patient 2A had severe amnionitis and recorded a temperature of 39.4°C and a heart rate of 135 bpm. She had arterial blood gases measured on three occasions and showed a mild metabolic acidosis. She was monitored closely in the recovery ward for eleven hours after delivery, but showed no signs of an MH reaction.
One other parturient developed a temperature of 37.8°C (>37.5°C is abnormal for labour) but this is not a significant temperature increase for the clinical MH grading scale and in this woman there were no other abnormal signs. All other parturients had temperatures within the normal range and <1.6°C change during labour.
Tachycardia >120 bpm developed in two deliveries. Patient 2A is referred to above.
Patient 6 was a single primiparous sixteen-year-old with no other features of MH. Anxiety probably accounted for her increased heart rate. Heart rate increases in other patients were unremarkable. The third woman (5A) tested in the early part of the six-year period when ABG indications were universal had a base deficit of 8 mmol/l, seven hours after the onset of labour and just after epidural placement. There was no associated tachycardia or rise in temperature. The acidosis resolved spontaneously. A similar event occurred during a subsequent minor surgical procedure. A base deficit of this degree would rank this parturient 2 to 3 on the MH clinical grading scale indicating MH was unlikely.
Creatine kinase (CK) was measured in ten deliveries (nine women) with a range of 30-1289 units (N 20-215 IU). CK was measured intrapartum in all these patients and three had pre-and postpartum measurements (2A, 6, 11). These results do not achieve significance on the MH clinical grading scale.
Minor blood pressure increases were measured in several women. Other parameters indicated above were within normal limits. (Table 3) Ephedrine (30 mg) was used in two deliveries for treatment of hypotension following epidural in labour. Adrenaline (60 to 125 µg) containing solutions were used in four epidurals. Patient 1B received a further epidural for perianal abscess drainage during pregnancy. The local anaesthetic contained 75 µg adrenaline.
Drugs Used
Syntocinon was used according to the usual obstetric protocols. Two women received syntocinon infusion to augment labour. On at least 17 occasions IM or IV boluses of syntocinon was given at delivery and on four occasions post partum syntocinon infusion was used. No ergometrine was used. Prostaglandins were used to augment one labour (9A). Amide local anaesthetics were used with all epidurals and dosages are shown in Table 3 . Bupivacaine or nupercaine were used for the spinals. Pethidine was used in six women and nitrous oxide in some deliveries. 
Neonatal Assessment
Apgar scores, temperature, respiratory and heart rate were measured in neonates. Apgar scores ranged from 6 to 10 at one minute (median 9) and 7 to 10 at five minutes (median 10) after delivery. Only one neonate had an Apgar score <9 at 5 minutes (Apgar 7), and she scored Apgar 10 at 10 minutes.
Only three babies had temperatures above 37.5°C, and all were normal by four hours after delivery.
Partner (Father of Newborn) at Risk of MH
There were five women who had MHS partners diagnosed by IVCT. These five women had eight deliveries in our hospital. Five were normal vaginal deliveries, two received epidurals for pain relief and two proceeded to emergency caesarean section (failure to progress, footling breech). One had a vaginal twin delivery. No extra monitoring was carried out during labour for the mother but the foetus was monitored by continuous CTG. Four babies were closely monitored after delivery according to the protocol, and four had routine hospital monitoring. No baby had symptoms or signs suggestive of malignant hyperthermia. The duration of labour ranged from 2 to 22 hours.
DISCUSSION
Two previous papers 3, 4 have discussed the management of a series of MH associated parturients and a number of papers have discussed the management of a single MHS parturient [3] [4] [5] [6] . This is the first series where all parturients were proven MHS with the exception of patient (6) (MHE). We initially identified four potential problems associated with the management of the MHS parturient: the risk of a stress-induced MH reaction in the mother during labour and delivery; the potential difficulties in management of a general anaesthetic for caesarean section; the issue of whether to use sympathomimetics and other drugs; the potential risks for the newborn such as placental transfer of drugs and stressinduced reaction in the foetus. Our approach to management has changed over the last six years as increasing experience and new information has reduced some of these concerns.
Labour is a stressful event. Bonica states labour pain is among the most intense pain recorded 7 . Both cortisol and catecholamines are significantly increased 8 . However, no documented MH episode has occurred in uncomplicated labour, and in fact only four reactions in the parturient associated with general anaesthesia have been documented [9] [10] [11] [12] , although others have occurred (Wedel D. W., personal communication). One reaction has been reported post partum following an epidural anaesthetic 13 and another during delivery under spinal anaesthesia 14 . This latter reaction would rank <3 on a clinical MH grading scale, indicating "somewhat less than likely chance of an MH event". Several MH reactions have been reported under regional anaesthesia in non-obstetric cases, but none is really conclusive. These reactions similarly rank equal to or less than 3 on the grading scale, although biochemical indices were incomplete [15] [16] [17] [18] [19] . Some concerns about the possibility of an awake MH reaction occurring in labour remain 3 . An association between human MH and generalized stress, susceptibility was first suggested by Wingard 20 and reports of reactions with triggerfree agents and non-anaesthetic related episodes have been reported infrequently [21] [22] [23] . Stress reactions have been reported more frequently in animals. Susceptible swine have an abnormal metabolic response to exercise, apprehension or excitement 24 . Farrowing does not appear to present a risk in susceptible swine (Gronert G 
.A., personal communication).
Presenting signs of an MH reaction can include tachypnoea, tachycardia, increased sweating and pyrexia, cardiac arrhythmias, decreased oxygen saturation and rigidity.
Metabolic and respiratory acidosis, elevated CK, myoglobinaemia and myoglobinuria are further biochemical evidence of an MH reaction. During the 20 deliveries involved in this study there were no abnormal changes in SpO 2 , BP, P a CO 2 or cardiac rhythm although measurements were incomplete. Modest increases in heart rate and temperature, a mild metabolic acidosis, and minor increases in CK were the only abnormalities detected. Leading signs of an MH episode may also be common to labour, e.g. tachycardia and pyrexia, and there may be some difficulty in the interpretation of abnormal signs in the MHS parturient. The MH clinical grading scale ranks the qualitative likelihood that an adverse anaesthetic event indicates malignant hyperthermia. It is intended to give the approximate likelihood of MH susceptibility after a clinical episode. Points are assigned for each clinical indicator present during a reaction, i.e. rigidity, muscle breakdown, respiratory acidosis, pyrexia, cardiac involvement, metabolic acidosis and response to dantrolene therapy. The raw score obtained from these indicators is designed to translate to an MH rank indicating the risk with which MH could occur from 1 ("almost never") to 6 ("almost certain") 2 . We have used this scale as the most reliable indicator of an MH reaction in this group of 20 deliveries.
Tachycardia is an early sign of MH and is mainly caused by increased sympathetic activity and hypermetabolism. Pulse rates of 100 bpm or higher depending on the position 25 are regarded as physiological during rest periods between uterine contractions in the second stage. The majority of patients with MH episodes develop a tachycardia of >120 bpm 26 . Two patients in this group had a pulse rate of >120 bpm. One developed severe amnionitis and the other was a nervous sixteen-year-old. There was no other evidence of MH.
Hackl found a temperature of >38.0°C a significant predictor of MH in patients investigated for MH episodes 27 . However, pyrexia may be a late sign of an MH reaction, and as an only sign it is not a good indicator of MH susceptibility 28 . Temperature increases up to 37.5°C are physiological in labour and even greater rises have been recorded with epidural analgesia 29 . We regard a temperature of >38.0°C as abnormal, and our policy now is not to undertake further investigations in labour until this temperature is exceeded.
Increases in serum lactate and CO 2 production are the earliest biochemical evidence of malignant hyperthermia. A maternal metabolic acidosis often occurs normally during the second stage of labour and a base deficit of 4.5 to 6 mmol can develop in a well managed labour depending on duration 30 . Patient 5A developed a base deficit of 8 mmol/l after a sevenhour labour. There were no other abnormal findings in this patient. The value of CK measurement is limited as small increases are associated with labour (2 to 3 times baseline) with a maximum increase about 24 hours post partum mainly due to myometrial contractile activity 31 . Exercise, pre-eclampsia and surgical trauma will also increase CK levels. Most of the reported increases are small and are much lower than the value of 20,000 IU which is regarded as a significant predictor of an MH episode 2 . Intrapartum CK was measured in ten patients with small increases recorded in two caesarean sections, and only two increases in labour despite labour lasting up to 27 hours.
There is little evidence that MH episodes occurred in this group of women. Our policy until recently has been to measure serial arterial blood gases during all caesarean sections. As there is very little evidence that MH reactions develop during elective regional anaesthesia, our policy now is to measure arterial blood gases intraoperatively for emergency caesarean section, and continue with serial measurements post partum if abnormal. Continuous ECG, SaO 2 , temperature, and intermittent NIBP continues for two hours in the recovery ward.
A number of studies have provided evidence that epidural analgesia in labour significantly reduces the release catecholamines, cortisol, ACTH and other hormones 32 . Increased catecholamines may have an adverse effect on the progress of labour and the foetus. Although there is little evidence that the stress of labour can trigger an MH reaction, it seems appropriate that a patient with a potential hypermetabolic response should be quiet and resting and an epidural should be planned for early in labour. An epidural is useful as it can also be topped up for emergency procedures. When an epidural is not in situ, a subarachnoid block can be rapidly established. With less concern about the use of sympathomimetics, the greater tendency to hypotension associated with spinal anaesthesia is not such a significant factor.
General anaesthesia was not required in this group of women. If general anaesthesia is required, a technique that avoids known MH triggering agents is necessary. Propofol and thiopentone have both been used safely for induction of anaesthesia in the pregnant patient 33 . A propofol infusion of 0.05 to 0.2 mg/kg/min resulted in adequate anaesthesia and good neonatal status in 37 women undergoing elective caesarean section 34 . This would be a good method of maintenance as the safety of propofol in MHS individuals has been confirmed by clinical experience 35 . Further opioid supplement could be used following delivery. Thiopentone, nitrous oxide, opioid, and midazolam can be used as an alternative, but results in more sedation and more risk of awareness, than propofol infusion.
Assessment of the airway is particularly important when using only nondepolarizing muscle relaxants for muscle relaxation during a rapid sequence induction. Rocuronium is a nondepolarizing aminosteroid with a short onset of action and is the best alternative to suxamethonium 36 , as it has a rapid onset time (60 seconds). Safety in MHS individuals has yet to be demonstrated by clinical trials and until this is achieved, atracurium remains the most satisfactory alternative.
Awake fibreoptic intubation is an alternative if airway difficulty is anticipated. This can be a stressful experience for the patient. Engorgement of vessels and increased vascularity of the nasopharyngeal area associated with pregnancy makes the oral approach mandatory.
Sympathomimetics are needed as vasopressors, tocolytics, and vasoconstrictors in obstetric anaesthesia, and for other incidental problems such as asthma. Confirmation of the safety of these drugs in MHS patients would be advantageous. The sympathetic nervous system is intimately involved with MH as evidenced by signs of sympathetic stimulation observed during a reaction, and markedly elevated catecholamines. The latter is thought to be a secondary event, as changes in metabolism precede the increase 37 . Early studies demonstrated that alpha adrenoceptor agonists in excessive doses induced an MH reaction in MHS swine 38 . These studies were not totally conclusive as it was later shown that alpha blockers provided only variable protection 39 . Gronert subsequently demonstrated that alpha and beta agonist stimulation in isolated preparations produce similar effects in susceptible and normal muscles. He also found that MH reactions occurred despite total spinal blockade and that sympathetic stimulation from hypercarbia failed to stimulate the hypermetabolism of malignant hyperthermia [39] [40] [41] . More recent studies have demonstrated that highdose noradrenaline infusion fails to trigger MH reactions in susceptible swine 37, 42 . Although ephedrine increased halothane-induced muscle contracture in vitro, the concentrations used were 1,000 to 2,000 times clinically relevant plasma concentration. There have been no adverse effects from the use of ephedrine clinically (Rosenberg H., personal communication, VIIIth Workshop on Malignant Hyperthermia, Minneapolis 1996). Adrenaline, noradrenaline, isoprenaline and salbutamol have no effect on muscle contractures 43, 44 . Sympathomimetics were regarded as contraindicated in our institution six years ago. Our policy has changed over this period as further information has become available. In this study sympathomimetics were used in seven deliveries without adverse effect, and a survey of major European and North American centres indicates that these agents are used without restriction by the majority in obstetric anaesthesia (Ranklev E., Wedel D. W., personal communication, VIIIth Workshop on Malignant Hyperthermia, Minneapolis 1996). The safety of these drugs is further confirmed by their use in fifteen non-obstetric MHS patients in our institution (MacLeod I. C., Pollock N., unpublished data). Some caution should be exercised as a tachycardia induced by these drugs could give rise to confusion.
The safety of amide local anaesthetics is well established 45 . The report by Tatsukawa 46 had too many complicating factors to suggest that MH is triggered by lignocaine. Bupivacaine up to 195 mg was used in patients in this study without apparent incident. Preservative-free syntocinon has no effect on contractures induced by halothane and caffeine in muscle from MHS swine. The standard preparation of syntocinon used in this hospital also contains chlorobutanol which reverses contractures induced by diagnostic reagents in MHS muscle 47 . Syntocinon 5 to 40 units was used in 18 of 20 MHS deliveries without problem. Magnesium sulphate is used in the management of pre-eclampsia and has been shown to attenuate MH reactions in susceptible swine. Direct skeletal muscle relaxation, depression of catecholamine activity and promotion of heat loss, all involving antagonism of calcium ion activity contribute to this effect 48 . Phenytoin, diazepam 49 and the usual antihypertensive agents similarly have been implicated in MH reactions. Prostaglandins have been used safely in MHS individuals (Langton E. E., unpublished data).
Dantrolene prophylaxis was first used by Harrison in 1977 50 and later by Free 51 in an MH-related child. Therapeutic blood vessels were defined by Flewellen 52 who also suggested intravenous prophylaxis immediately prior to anaesthesia. Subsequently in 1983 53 oral and later intravenous 54 administration of prophylactic dantrolene in labour showed no adverse effects on the mother or neonate. A large study demonstrated lack of adverse effects with oral administration in the foetus and neonate with only minor maternal side-effects 55 . In all but one of these studies however, recommended therapeutic levels of dantrolene were not achieved and neonatal assessment was limited.
The efficacy of dantrolene prophylaxis has never been proven and several series have reported minimal triggering of MH in the absence of dantrolene pre-treatment while using trigger-free anaesthetic agents [56] [57] [58] . Significant side-effects are common with dantrolene therapy and a recent small study showed that minor side-effects occurred in all patients administered dantrolene intravenously 59 . Potentially severe interactions have been described with verapamil and bupivacaine [60] [61] [62] and intravenous prophylaxis has been associated with post partum uterine atony 63 . No case of MH which failed to respond to intravenous dantrolene has been reported, providing the diagnosis was established early and an adequate dose of intravenous dantrolene administered 64 . Restriction of dantrolene to the treatment of MH reactions has therefore been recommended, although in planned prolonged procedures particular caution should be exercised 65 . Availability of dantrolene in the operating theatre and appropriate monitoring is mandatory in all MHS cases. Dantrolene prophylaxis was not used in any of the 20 deliveries in this series.
Reports of clinical MH are rare in the potentially MHS foetus 10, 13, 66 . Triggering agents were used in the 66 . The Apgar score, although a nonspecific indicator, measures neonatal dysfunction, and in 28 newborn in this study Apgar scores were essentially normal at five minutes. Little evidence exists to suggest that the stress of birth can trigger an MH episode in susceptible newborn, although careful observation in the early post partum period is advised.
Potent inhalational agents rapidly cross the placenta and should be avoided in partners of MHS fathers. Using a biological assay method for measurement Kvisselgaard detected suxamethonium in umbilical vein blood after a maternal dose of 300 mg of suxamethonium 67 . A more sensitive radioimmunoassay measurement of suxamethonium in animals found foetal transmission of the drug at doses of 2 mg/kg 68 and prolonged paralysis of the newborn in a mother with serum cholinesterase deficiency demonstrates the placenta is a relative and not absolute barrier to the passage of ionized muscle relaxants 69 . Suxamethonium should be avoided in women with MHS partners.
Education of patients, midwives, anaesthetic and surgical staff has increased the awareness of MH susceptibility and an effective screening for those susceptible to MH is now in place. Delivery at a hospital with specialist obstetric and anaesthetic staff is strongly recommended for all MHS parturients but some women decline and opt for smaller maternity units closer to home. Midwives in these situations are encouraged to notify the base hospital immediately labour commences. A few parturients have preferred home delivery, knowing the risks involved. This has also affected the monitoring and investigation we carry out at base hospital-if we do too much these women will choose home delivery. We prefer all MHS parturients to deliver in our institution with the most appropriate monitoring. This is a problem which has been present for some years and remains unresolved at present.
In conclusion, four concerns were identified at the commencement of the study. There is little evidence that the stress of labour can trigger an MH episode although biochemical indices were incomplete in this study. General anaesthesia was not required over this study period but a literature survey indicates that a propofol induction and maintenance if general anaesthesia for caesarean section is required is safe for both mother and baby. One-third of the parturients received sympathomimetics without adverse effect. Inhalational anaesthetic agents and suxamethonium should be avoided in partners of MHS fathers as well as MHS women.
